April 27, 2021
						
						5124
						
						No Comments
					
				‘We like to start with the business problem.What’s the challenge?What is the brand facing?’ We met Kevin Nalty, to talk about the acceleration of positive changes in pharma strategy during the pandemic.
 
									
									 
									
									